BMY Bristol Myers Squibb
NYSE · SEC CIK 14272 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $2.29M 3 sales by 3 insiders
- Filings on record
- 369 since 2021-07-01, latest 2026-09-10 16:37
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Elkins David V | EVP, CFO | — | $1.85M |
| Massacesi Cristian | EVP, Chief Med Offr, Head of Dev | — | $403.5K |
| Holzer Phil M | SVP, Ctrl | — | $33.8K |
| Short Bartie Wendy | EVP, Corp. Affairs | — | — |
| Hoch Lynelle | Pres, Cell Therapy Org | — | — |
| Poole Ahn Amanda | EVP, CHRO | — | — |
| Gallman Cari | EVP, GC | — | — |
| Lenkowsky Adam | EVP, Chief Commercial Off | — | — |
| Shanahan Karin | EVP, Chief Supply Chain, Ops | — | — |
| Meyers Gregory Scott | EVP, Chief Digital, Tech Off | — | — |
Transactions 333
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-12 | 2025-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +11.3K | 20.1K | +127% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | J - Other | $0.00 | -3,121 | 17.7K | -15% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | F - Tax | $63.11 | -3,610 | 12.4K | -23% | -$227.8K |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | M - OptEx | $0.00 | +7,446 | 7,920 | +1,571% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | J - Other | $0.00 | -2,213 | 6,070 | -27% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | F - Tax | $63.11 | -2,248 | 4,711 | -32% | -$141.9K |
| DM | 2025-03-12 | 2025-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +7,588 | 11.6K | +188% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | J - Other | $0.00 | -2,345 | 9,612 | -20% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | F - Tax | $63.11 | -1,940 | 5,705 | -25% | -$122.4K |
| DM | 2025-03-12 | 2025-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | M - OptEx | $0.00 | +23.1K | 26.9K | +611% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | J - Other | $0.00 | -7,333 | 20.7K | -26% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | F - Tax | $63.11 | -6,711 | 16.1K | -29% | -$423.5K |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | -12.7K | 88.5K | -13% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $63.11 | -16.1K | 79.3K | -17% | -$1.01M |
| DM | 2025-03-12 | 2025-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +44.1K | 73.9K | +148% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Poole Ahn Amanda | EVP, CHRO | J - Other | $0.00 | -2,119 | 3,502 | -38% | $0 |
| DM | 2025-03-12 | 2025-03-10 | BMY | Poole Ahn Amanda | EVP, CHRO | F - Tax | $63.11 | -2,273 | 3,260 | -41% | -$143.4K |
| DM | 2025-03-12 | 2025-03-10 | BMY | Poole Ahn Amanda | EVP, CHRO | M - OptEx | $0.00 | +7,164 | 3,643 | New | $0 |
| D | 2025-03-04 | 2025-03-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $59.62 | -1,630 | 8,789 | -16% | -$97.2K |
| D | 2025-03-04 | 2025-03-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +3,286 | 10.4K | +46% | $0 |
| 2025-02-21 | 2025-02-20 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | P - Purchase | $55.05 | +2,000 | 104.6K | +2% | +$110.1K | |
| 2025-02-19 | 2025-02-14 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $54.84 | +1,823 | 63.9K | +3% | +$100.0K | |
| D | 2025-02-04 | 2025-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | M - OptEx | $0.00 | +10.1K | 10.9K | +1,292% | $0 |
| D | 2025-02-04 | 2025-02-01 | BMY | Hickey Benjamin | Pres, RayzeBio Org | F - Tax | $58.95 | -3,725 | 7,133 | -34% | -$219.6K |
| D | 2025-02-04 | 2025-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | F - Tax | $58.95 | -833 | 6,996 | -11% | -$49.1K |
| D | 2025-02-04 | 2025-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | M - OptEx | $0.00 | +2,543 | 7,829 | +48% | $0 |
| 2024-11-05 | 2024-11-04 | BMY | Holzer Phil M | SVP, Ctrl | S - Sale | $55.62 | -700 | 11.8K | -6% | -$38.9K | |
| 2024-11-05 | 2024-11-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | P - Purchase | $54.68 | +1,830 | 62.1K | +3% | +$100.1K | |
| D | 2024-11-05 | 2024-11-01 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $54.32 | -1,488 | 102.6K | -1% | -$80.8K |
| D | 2024-11-05 | 2024-11-01 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +2,964 | 104.2K | +3% | $0 |
| D | 2024-11-05 | 2024-11-01 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -55 | 104.1K | -0.1% | $0 |
| D | 2024-10-03 | 2024-10-02 | BMY | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +4,558 | 6,667 | +216% | $0 |
| D | 2024-10-03 | 2024-10-02 | BMY | Gallman Cari | EVP, Corp. Affairs | F - Tax | $53.76 | -1,648 | 5,019 | -25% | -$88.6K |
| D | 2024-08-05 | 2024-08-01 | BMY | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +1,061 | 2,493 | +74% | $0 |
| D | 2024-08-05 | 2024-08-01 | BMY | Gallman Cari | EVP, Corp. Affairs | F - Tax | $48.17 | -384 | 2,109 | -15% | -$18.5K |
| D | 2024-04-02 | 2024-04-01 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | F - Tax | $52.99 | -1,196 | 5,336 | -18% | -$63.4K |
| D | 2024-04-02 | 2024-04-01 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | M - OptEx | $0.00 | +3,306 | 6,532 | +102% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Poole Ahn Amanda | EVP, Chief Human Resources | F - Tax | $53.79 | -1,375 | 701 | -66% | -$74.0K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Poole Ahn Amanda | EVP, Chief Human Resources | M - OptEx | $0.00 | +5,458 | 628 | New | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Poole Ahn Amanda | EVP, Chief Human Resources | J - Other | $0.00 | -1,659 | 529 | -76% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Holzer Phil M | SVP, Ctrl | J - Other | $0.00 | -1,682 | 10.9K | -13% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Holzer Phil M | SVP, Ctrl | F - Tax | $53.79 | -1,389 | 12.5K | -10% | -$74.7K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Holzer Phil M | SVP, Ctrl | M - OptEx | $0.00 | +5,520 | 10.6K | +108% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | J - Other | $0.00 | -11.7K | 50.8K | -19% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $53.79 | -13.6K | 49.0K | -22% | -$734.2K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +38.4K | 53.9K | +248% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | F - Tax | $53.79 | -1,965 | 11.3K | -15% | -$105.7K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +9,143 | 15.2K | +151% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Plenge Robert M | EVP, Chief Research Off | J - Other | $0.00 | -2,789 | 7,763 | -26% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Lenkowsky Adam | EVP, Chief Commercial Off | F - Tax | $53.79 | -4,323 | 6,650 | -39% | -$232.5K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Lenkowsky Adam | EVP, Chief Commercial Off | M - OptEx | $0.00 | +15.0K | 2,224 | New | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Lenkowsky Adam | EVP, Chief Commercial Off | J - Other | $0.00 | -4,569 | 9,885 | -32% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | J - Other | $0.00 | -1,317 | 707 | -65% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | F - Tax | $53.79 | -1,308 | 257 | -84% | -$70.4K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Hoch Lynelle | Pres, Cell Therapy Org | M - OptEx | $0.00 | +4,351 | 801 | New | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | F - Tax | $53.79 | -19.4K | 87.9K | -18% | -$1.04M |
| DM | 2024-03-12 | 2024-03-10 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | M - OptEx | $0.00 | +54.6K | 88.4K | +162% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | BOERNER CHRISTOPHER S. | CEO, Dir | J - Other | $0.00 | -16.7K | 87.5K | -16% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | LEUNG SANDRA | EVP, GC | F - Tax | $53.79 | -16.7K | 333.8K | -5% | -$896.1K |
| DM | 2024-03-12 | 2024-03-10 | BMY | LEUNG SANDRA | EVP, GC | M - OptEx | $0.00 | +46.8K | 339.7K | +16% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | LEUNG SANDRA | EVP, GC | J - Other | $0.00 | -14.2K | 336.3K | -4% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | M - OptEx | $0.00 | +2,761 | 2,655 | New | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | J - Other | $0.00 | -839 | 666 | -56% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Gallman Cari | EVP, Corp. Affairs | F - Tax | $53.79 | -696 | 561 | -55% | -$37.4K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Caforio Giovanni | Executive COB of the Board, Dir | M - OptEx | $0.00 | +190.1K | 390.9K | +95% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Caforio Giovanni | Executive COB of the Board, Dir | F - Tax | $53.79 | -67.8K | 386.8K | -15% | -$3.65M |
| DM | 2024-03-12 | 2024-03-10 | BMY | Caforio Giovanni | Executive COB of the Board, Dir | J - Other | $0.00 | -57.5K | 396.8K | -13% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Elkins David V | EVP, CFO | F - Tax | $53.79 | -18.5K | 176.9K | -9% | -$996.3K |
| DM | 2024-03-12 | 2024-03-10 | BMY | Elkins David V | EVP, CFO | J - Other | $0.00 | -19.4K | 175.4K | -10% | $0 |
| DM | 2024-03-12 | 2024-03-10 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +64.3K | 181.1K | +55% | $0 |
| D | 2024-02-05 | 2024-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | M - OptEx | $0.00 | +2,543 | 6,040 | +73% | $0 |
| D | 2024-02-05 | 2024-02-01 | BMY | Meyers Gregory Scott | EVP, Chief Digital, Tech Off | F - Tax | $48.67 | -754 | 5,286 | -12% | -$36.7K |
| 2023-12-07 | 2023-12-05 | BMY | BOERNER CHRISTOPHER S. | CEO | P - Purchase | $49.78 | +2,000 | 82.7K | +2% | +$99.6K | |
| D | 2023-12-05 | 2023-12-02 | BMY | BOERNER CHRISTOPHER S. | CEO | F - Tax | $50.10 | -1,350 | 80.7K | -2% | -$67.6K |
| D | 2023-12-05 | 2023-12-02 | BMY | BOERNER CHRISTOPHER S. | CEO | M - OptEx | $0.00 | +2,638 | 82.0K | +3% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Elkins David V | EVP, CFO | M - OptEx | $0.00 | +8,792 | 172.3K | +5% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Elkins David V | EVP, CFO | F - Tax | $50.10 | -3,730 | 168.6K | -2% | -$186.9K |
| D | 2023-12-05 | 2023-12-02 | BMY | Plenge Robert M | EVP, Chief Research Off | M - OptEx | $0.00 | +616 | 7,200 | +9% | $0 |
| D | 2023-12-05 | 2023-12-02 | BMY | Plenge Robert M | EVP, Chief Research Off | F - Tax | $50.10 | -274 | 6,926 | -4% | -$13.7K |
| 2023-11-30 | 2023-11-28 | BMY | BOERNER CHRISTOPHER S. | CEO | P - Purchase | $48.86 | +3,071 | 79.4K | +4% | +$150.0K | |
| 2023-11-24 | 2023-11-21 | BMY | LEUNG SANDRA | EVP, GC | J - Other | $48.75 | -9,830 | 331.4K | -3% | -$479.2K | |
| I | 2023-11-24 | 2023-11-21 | BMY | LEUNG SANDRA | EVP, GC | J - Other | $48.75 | +9,830 | 93.4K | +12% | +$479.2K |
| 2023-11-21 | 2023-11-20 | BMY | Samuels Theodore R. II | Dir | P - Purchase | $49.81 | +8,500 | 35.5K | +31% | +$423.4K | |
| 2023-10-12 | 2023-10-10 | BMY | Caforio Giovanni | CEO, Board COB, Dir | G - Gift | $0.00 | -440 | 367.5K | -0.1% | $0 | |
| 2023-08-28 | 2023-08-24 | BMY | Powell Ann | EVP, Chief Human Resources | S - Sale | $61.25 | -18.0K | 27.9K | -39% | -$1.10M | |
| 2023-08-07 | 2023-08-03 | BMY | Plenge Robert M | EVP, Chief Research Off | S - Sale | $61.14 | -732 | 6,584 | -10% | -$44.8K | |
| D | 2023-07-05 | 2023-07-01 | BMY | Weese Michelle | EVP, Corp. Affairs | M - OptEx | $0.00 | +1,885 | 4,135 | +84% | $0 |
| D | 2023-07-05 | 2023-07-01 | BMY | Weese Michelle | EVP, Corp. Affairs | F - Tax | $63.95 | -682 | 3,453 | -16% | -$43.6K |
| D | 2023-07-05 | 2023-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | M - OptEx | $0.00 | +9,357 | 52.0K | +22% | $0 |
| D | 2023-07-05 | 2023-07-01 | BMY | Hirawat Samit | EVP, Chief Med.Offr, Drug Dev | F - Tax | $63.95 | -4,787 | 47.2K | -9% | -$306.1K |
| D | 2023-06-06 | 2023-06-03 | BMY | Lenkowsky Adam | EVP, Chief Commercial Off | F - Tax | $65.66 | -551 | 526 | -51% | -$36.2K |
| D | 2023-06-06 | 2023-06-03 | BMY | Lenkowsky Adam | EVP, Chief Commercial Off | M - OptEx | $0.00 | +1,077 | 1,077 | New | $0 |
| 2023-05-04 | 2023-05-03 | BMY | VESSEY RUPERT | EVP, Pres, Research | S - Sale | $67.06 | -50.4K | 47.8K | -51% | -$3.38M | |
| DM | 2023-05-03 | 2023-05-02 | BMY | Greenlees Sharon | SVP, Ctrl | M - OptEx | $0.00 | +1,017 | 689 | New | $0 |
| D | 2023-05-03 | 2023-05-02 | BMY | Greenlees Sharon | SVP, Ctrl | J - Other | $0.00 | -62 | 627 | -9% | $0 |
| DM | 2023-05-03 | 2023-05-02 | BMY | Greenlees Sharon | SVP, Ctrl | F - Tax | $68.10 | -346 | 609 | -36% | -$23.6K |
| D | 2023-04-04 | 2023-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | J - Other | $0.00 | +1,190 | 35.2K | +3% | $0 |
| DM | 2023-04-04 | 2023-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | F - Tax | $69.31 | -3,198 | 33.2K | -9% | -$221.7K |
| DM | 2023-04-04 | 2023-04-01 | BMY | Mily Elizabeth | EVP, Strategy, BD | M - OptEx | $0.00 | +6,346 | 35.9K | +21% | $0 |
| D | 2023-04-04 | 2023-04-01 | BMY | Shanahan Karin | EVP, Glob. Prod. Dev, Supply | M - OptEx | $0.00 | +3,306 | 4,918 | +205% | $0 |
Purchase Sale Sale after option exercise All abbreviations